Are Extrasynaptic GABA A Receptors Important Targets for Sedative/Hypnotic Drugs?

• Published in: The Journal of neuroscience Vol. 32; no. 11; pp. 3887 - 3897
• Main Authors: Houston, Catriona M., McGee, Thomas P., MacKenzie, Georgina, Troyano-Cuturi, Kevin, Rodriguez, Pablo Mateos, Kutsarova, Elena, Diamanti, Efthymia, Hosie, Alastair M., Franks, Nicholas P., Brickley, Stephen G.
• Format: Journal Article
• Language: English
• Published: 14.03.2012
• ISSN: 0270-6474; 1529-2401
• DOI: 10.1523/JNEUROSCI.5406-11.2012

High-affinity extrasynaptic GABA A receptors are persistently activated by the low ambient GABA levels that are known to be present in extracellular space. The resulting tonic conductance generates a form of shunting inhibition that is capable of altering cellular and network behavior. It has been suggested that this tonic inhibition will be enhanced by neurosteroids, antiepileptics, and sedative/hypnotic drugs. However, we show that the ability of sedative/hypnotic drugs to enhance tonic inhibition in the mouse cerebellum will critically depend on ambient GABA levels. For example, we show that the intravenous anesthetic propofol enhances tonic inhibition only when ambient GABA levels are <100 n m . More surprisingly, the actions of the sleep-promoting drug 4,5,6,7-tetrahydroisothiazolo-[5,4-c]pyridin-3-ol (THIP) are attenuated at ambient GABA levels of just 20 n m . In contrast, our data suggest that neurosteroid enhancement of tonic inhibition will be greater at high ambient GABA concentrations. We present a model that takes into account realistic estimates of ambient GABA levels and predicted extrasynaptic GABA A receptor numbers when considering the ability of sedative/hypnotic drugs to enhance tonic inhibition. These issues will be important when considering drug strategies designed to target extrasynaptic GABA A receptors in the treatment of sleep disorders and other neurological conditions.